Personalized nutrition for the prevention of cardiovascular disease: A future perspective

Journal of Human Nutrition and Dietetics

Volumn 21, Issue 4, 2008, Pages 306-316

  Lovegrove, J A ^a   Gitau, R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

apoE; Cardiovascular disease risk; Dietary fat; Nutrigenetics; Peroxisome proliferator activated receptor

Indexed keywords

APOLIPOPROTEIN E; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET THERAPY; EVIDENCE BASED MEDICINE; FAT INTAKE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LIPID COMPOSITION; MEDICAL ETHICS; NUTRIGENOMICS; NUTRITIONAL COUNSELING; PUBLIC HEALTH; REVIEW; RISK REDUCTION;

APOLIPOPROTEINS; CARDIOVASCULAR DISEASES; DIET; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; NUTRIGENOMICS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 47949118691     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/j.1365-277X.2008.00889.x     Document Type: Review

References (62)

1. Allender, S., Peto, V., Scarborough, P., Boxer, A. & Rayner, M. (2007) Coronary Heart Disease Statistics 2007. London: British Heart Foundation.
2. Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Bolk, S., Brewer, C., Tuomi, T., Gaudet, D., Hudson, T.J., Daly, M., Groop, L. & Lander, E.S. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26, 76-80.
3. Auwerx, J. (1999) PPARgamma, the ultimate thrifty gene. Diabetologia 42, 1033-1049.
4. BHF (2007) Coronary Heart Disease Statistics. London: BHF. Available at http://www.heartstats.org (accessed on 1 June 2008).
5. Brady, L.M., Lovegrove, S.S., Lesauvage, S.V., Gower, B.A., Minihane, A.M., Williams, C.M. & Lovegrove, J.A. (2004) Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. Am. J. Clin. Nutr. 79, 983-991.
6. Bucher, H.C., Hengstler, P., Schindler, C. & Meier, G. (2002) N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials. Am. J. Med. 112, 298-304.
7. Burr, L., Gilbert, J., Holliday, R., Elwood, P., Fehily, A., Rodgers, S., Sweetnam, P.M. & Deadman, N. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 2, 757-761.
8. Cannon, G. & Leitzmann, C. (2005) The new nutrition science project. Public Health Nutr. 8, 673-694.
9. Cecil, J.E., Watt, P., Palmer, C.N. & Hetherington, M. (2006) Energy balance and food intake: The role of PPARgamma gene polymorphisms. Physiol. Behav. 88, 227-233.
10. CogentResearch. (2003) Congent Syndicated Genomics Attitudes and Trends: Consumers. Available at http://www.cogentresearch.com/products/ CGAT%20Brochure.pdf (accessed on 1 June 2008).
11. Corthesy-Theulaz, I., den Dunnen, J.T., Ferre, P., Geurts, J.M., Muller, M., van Belzen, N. & van Ommen, B. (2005) Nutrigenomics: The impact of biomics technology on nutrition research. Ann. Nutr. Metab. 49, 355-365.
12. Couture, P., Archer, W.R., Lamarche, B., Landry, N., Deriaz, O., Corneau, L., Bergeron, J. & Bergeron, N. (2003) Influences of apolipoprotein E polymorphism on the response of plasma lipids to the ad libitum consumption of a high-carbohydrate diet compared with a high-monounsaturated fatty acid diet. Metabolism 52, 1454-1459.
13. Demant, T., Bedford, D., Packard, C.J. & Shepherd, J. (1991) Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J. Clin. Invest. 88, 1490-1501.
14. Dreon, D.M., Fernstrom, H.A., Miller, B. & Krauss, R.M. (1995) Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arterioscler. Thromb. Vasc. Biol. 15, 105-111.
15. Eichner, J.E., Dunn, S.T., Perveen, G., Thompson, D.M., Stewart, K.E. & Stroehla, B.C. (2002) Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am. J. Epidemiol. 155, 487-495.
16. Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M., Lindgren, C.M., Perry, J.R., Elliott, K.S., Lango, H., Rayner, N.W., Shields, B., Harries, L.W., Barrett, J.C., Ellard, S., Groves, C.J., Knight, B., Patch, A.M., Ness, A.R., Ebrahim, S., Lawlor, D.A., Ring, S.M., Ben-Shlomo, Y., Jarvelin, M.R., Sovio, U., Bennett, A.J., Melzer, D., Ferrucci, L., Loos, R.J., Barroso, I., Wareham, N.J., Karpe, F., Owen, K.R., Cardon, L.R., Walker, M., Hitman, G.A., Palmer, C.N., Doney, A.S., Morris, A.D., Smith, G.D., Hattersley, A.T. & McCarthy, M.I. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894.
17. Frederiksen, L., Brodbaek, K., Fenger, M., Jorgensen, T., Borch-Johnsen, K., Madsbad, S. & Urhammer, S.A. (2002) Studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J. Clin. Endocrinol. Metab. 87, 3989-3992.
18. Friedlander, Y., Berry, E.M., Eisenberg, S., Stein, Y. & Leitersdorf, E. (1995) Plasma lipids and lipoproteins response to a dietary challenge: Analysis of four candidate genes. Clin. Genet. 47, 1-12.
19. Gonzalez Sanchez, J.L., Serrano Rios, M., Fernandez Perez, C., Laakso, M. & Martinez Larrad, M.T. (2002) Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur. J. Endocrinol. 147, 495-501.
20. Henderson, L., Gregory, J., Irving, K. & Swan, G. (2003) The National Diet and Nutrition Survey: Adults aged 19-64 years. London: HMSO.
21. Hinds, D., Stuve, L., Nilsen, G.B., Halperin, E., Eskin, E., Ballinger, D., Frazer, F. & Cox, D. (2005) Whole-genome patterns of common DNA variation in three human popultions. Science 307, 1052-1053.
22. Huang, Y., Ji, Z.S., Brecht, W.J., Rall, S.C. Jr, Taylor, J.M. & Mahley, R.W. (1999) Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis. Arterioscler. Thromb. Vasc. Biol. 19, 2952-2959.
23. Kaput, J. & Rodriguez, R.L. (2004) Nutritional genomics: The next frontier in the postgenomic era. Physiol. Genomics 16, 166-177.
24. Kesaniemi, Y.A., Ehnholm, C. & Miettinen, T.A. (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest. 80, 578-581.
25. Kris-Etherton, P., Harris, W. & Appel, L. (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 23, E31-E42.
26. Lehtimaki, T., Moilanen, T., Solakivi, T., Laippala, P. & Ehnholm, C. (1992) Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Ann. Med. 24, 61-66.
27. Lindi, V.I., Uusitupa, M.I., Lindstrom, J., Louheranta, A., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M. & Tuomilehto, J. (2002) Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51, 2581-2586.
28. Lindi, V., Schwab, U., Louheranta, A., Laakso, M., Vessby, B., Hermansen, K., Storlien, L., Riccardi, G. & Rivellese, A.A. (2003) Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol. Genet. Metab. 79, 52-60.
29. Lopez-Miranda, J., Ordovas, J.M., Mata, P., Lichtenstein, A.H., Clevidence, B., Judd, J.T. & Schaefer, E.J. (1994) Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J. Lipid Res. 35, 1965-1975.
30. Lovegrove, J.A., Lovegrove, S.S., Lesauvage, S.V., Brady, L.M., Saini, N., Minihane, A.M. & Williams, C.M. (2004) Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians. Am. J. Clin. Nutr. 79, 974-982.
31. Luan, J., Browne, P.O., Harding, A.H., Halsall, D.J., O'Rahilly, S., Chatterjee, V.K. & Wareham, N.J. (2001) Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50, 686-689.
32. Mahley, R.W. (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
33. Manttari, M., Koskinen, P., Ehnholm, C., Huttunen, J.K. & Manninen, V. (1991) Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 40, 217-221.
34. Masson, L.F., McNeill, G. & Avenell, A. (2003) Genetic variation and the lipid response to dietary intervention: A systematic review. Am. J. Clin. Nutr. 77, 1098-1111.
35. McCluskey, S., Baker, D., Percy, D., Lewis, P. & Middleton, E. (2007) Reductions in cardiovascular risk in association with population screening: A 10-year longitudinal study. J. Public Health (Oxf) 29, 379-387.
36. McVean, G., Spencer, C. & Chaix, R. (2005) Perspectives on human genetic variation from the HapMap project. PLoS Genet. 1, e54.
37. Memisoglu, A., Hu, F.B., Hankinson, S.E., Liu, S., Meigs, J.B., Altshuler, D.M., Hunter, D.J. & Manson, J.E. (2003a) Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes. Diabetes Care 26, 2915-2917.
38. Memisoglu, A., Hu, F.B., Hankinson, S.E., Manson, J.E., De Vivo, I., Willett, W.C. & Hunter, D.J. (2003b) Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum. Mol. Genet. 12, 2923-2929.
39. Miettinen, T.A., Gylling, H., Vanhanen, H. & Ollus, A. (1992) Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler. Thromb. 12, 1044-1052.
40. Minihane, A.M., Khan, S., Leigh-Firbank, E.C., Talmud, P., Wright, J.W., Murphy, M.C., Griffin, B.A. & Williams, C.M. (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler. Thromb. Vasc. Biol. 20, 1990-1997.
41. Minihane, A.M., Jofre-Monseny, L., Olano-Martin, E. & Rimbach, G. (2007) ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc. Nutr. Soc. 66, 183-197.
42. Moreno, J.A., Perez-Jimenez, F., Marin, C., Gomez, P., Perez-Martinez, P., Moreno, R., Bellido, C., Fuentes, F. & Lopez-Miranda, J. (2004) The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J. Nutr. 134, 2517-2522.
43. Mutch, D.M., Wahli, W. & Williamson, G. (2005) Nutrigenomics and nutrigenetics: The emerging faces of nutrition. FASEB J. 19, 1602-1616.
44. Nicklas, B.J., van Rossum, E.F., Berman, D.M., Ryan, A.S., Dennis, K.E. & Shuldiner, A.R. (2001) Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 50, 2172-2176.
45. Olefsky, J.M. & Saltiel, A.R. (2000) PPAR gamma and the treatment of insulin resistance. Trends Endocrinol. Metab. 11, 362-368.
46. Ordovas, J.M. & Mooser, V. (2004) Nutrigenomics and nutrigenetics. Curr. Opin. Lipidol. 15, 101-108.
47. Poirier, O., Nicaud, V., Cambien, F. & Tiret, L. (2000) The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene is not associated with postprandial responses to glucose or fat tolerance tests in young healthy subjects: The European Atherosclerosis Research Study II. J. Mol. Med. 78, 346-351.
48. Rall, S.C. Jr, Weisgraber, K.H. & Mahley, R.W. (1982) Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem. 257, 4171-4178.
49. Robitaille, J., Despres, J.P., Perusse, L. & Vohl, M.C. (2003) The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: Results from the Quebec Family Study. Clin. Genet. 63, 109-116.
50. Rosen, E.D. & Spiegelman, B.M. (2001) PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276, 37731-37734.
51. Sarkkinen, E., Korhonen, M., Erkkila, A., Ebeling, T. & Uusitupa, M. (1998) Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am. J. Clin. Nutr. 68, 1215-1222.
52. Schaefer, E.J., Lichtenstein, A.H., Lamon-Fava, S., Contois, J.H., Li, Z., Rasmussen, H., McNamara, J.R. & Ordovas, J.M. (1995) Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler. Thromb. Vasc. Biol. 15, 1079-1085.
53. Schaefer, E.J., Lamon-Fava, S., Ausman, L.M., Ordovas, J.M., Clevidence, B.A., Judd, J.T., Goldin, B.R., Woods, M., Gorbach, S. & Lichtenstein, A.H. (1997) Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am. J. Clin. Nutr. 65, 823-830.
54. Singh, P., Singh, M. & Mastana, S. (2006) ApoE distribution in world populations with new data from India and the UK. Ann. Hum. Biol. 33, 297-308.
55. Song, Y., Stampfer, M.J. & Liu, S. (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 141, 137-147.
56. Soriguer, F., Morcillo, S., Cardona, F., Rojo-Martinez, G., de la Cruz Almaraz, M., Ruiz de Adana Mde, L., Olveira, G., Tinahones, F. & Esteva, I. (2006) Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J. Nutr. 136, 2325-2330.
57. Stratakis, C.A., Lafferty, A., Taymans, S.E., Gafni, R.I., Meck, J.M. & Blancato, J. (2000) Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: Molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419-D16S503). J. Clin. Endocrinol. Metab. 85, 3396-3401.
58. Stumvoll, M., Wahl, H.G., Loblein, K., Becker, R., Machicao, F., Jacob, S. & Haring, H. (2001) Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 50, 876-881.
59. Tikkanen, M.J., Huttunen, J.K., Ehnholm, C. & Pietinen, P. (1990) Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 10, 285-288.
60. Tso, T.K., Park, S., Tsai, Y.H., Williams, G. & Snook, J.T. (1998) Effect of apolipoprotein E polymorphism on serum lipoprotein response to saturated fatty acids. Lipids 33, 139-148.
61. Vaccaro, O., Mancini, F.P., Ruffa, G., Sabatino, L., Iovine, C., Masulli, M., Colantuoni, V. & Riccardi, G. (2002) Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals. Clin. Endocrinol. (Oxf) 57, 481-486.
62. Weisgraber, K.H. (1990) Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31, 1503-1511.